Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression

L Roseman, DJ Nutt, RL Carhart-Harris - Frontiers in Pharmacology, 2018 - frontiersin.org

Abstract

Introduction: It is a basic principle of the 'psychedelic'treatment model that the quality of the acute experience mediates long-term improvements in mental health. In the present paper we sought to test this using data from a clinical trial assessing psilocybin for treatment …

Last updated: Jul 27, 2020